4.8 Article

MTSS1 is a metastasis driver in a subset of human melanomas

Journal

NATURE COMMUNICATIONS
Volume 5, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms4465

Keywords

-

Funding

  1. FWF-Austrian Science Fund [L590-B12, P21292-B09]
  2. Cancer Society of Finland
  3. GBPM graduate school
  4. Vienna Science and Technology Fund (WWTF) [MA09-004]
  5. Academy of Finland (AKA) [120098, 120098] Funding Source: Academy of Finland (AKA)
  6. Austrian Science Fund (FWF) [P21292] Funding Source: Austrian Science Fund (FWF)
  7. Cancer Foundation Finland sr [110091, 120098] Funding Source: researchfish

Ask authors/readers for more resources

In cancers with a highly altered genome, distinct genetic alterations drive subsets rather than the majority of individual tumours. Here we use a sequential search across human tumour samples for transcript outlier data points with associated gene copy number variations that correlate with patient's survival to identify genes with pro-invasive functionality. Employing loss and gain of function approaches in vitro and in vivo, we show that one such gene, MTSS1, promotes the ability of melanocytic cells to metastasize and engages actin dynamics via Rho-GTPases and cofilin in this process. Indeed, high MTSS1 expression defines a subgroup of primary melanomas with unfavourable prognosis. These data underscore the biological, clinical and potential therapeutic implications of molecular subsets within genetically complex cancers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available